The archive

137 stories from 60 issues. Filter by industry, type of news, date or company, and choose how much to read.

6 stories

Clear filters
  1. 17 NovNew

    Launch

    OpenAI's healthcare ChatGPT now operates clinical software for staff

    Why it matters If you run a healthcare organisation, you can now pilot AI on admin work across your existing software, not only Q&A.

    Impact Healthcare organisations can pilot agents that operate their software to cut admin workload.

    What happened OpenAI has expanded ChatGPT for Healthcare with AI assistants that operate software on a user's behalf, better answers to clinical questions, and add-ons that connect to healthcare systems.

  2. 4 NovNew

    Launch

    Google's AI helper cuts a days-long drug design cycle to about an hour

    Why it matters Drug discovery teams can cut one design-and-data cycle from several days to about an hour, based on Google DeepMind's lung cancer demo.

    Impact Drug design cycles shrink from days to about an hour with AI agents.

    What happened Google DeepMind added a set of Cheminformatics Skills to its Google Antigravity workspace. In a lung cancer demo, an AI agent screened a large pool of molecules, ran matched molecular pair analysis and proposed new ring-shaped candidates with synthesis routes in about an hour, versus days per cycle.

  3. 4 NovNew

    Programme

    Barnsley care, building and small firms get £800,000 of funded AI training for staff

    Why it matters Barnsley employers in care, construction and small business can get funded AI training for staff, with the pilot's results possibly shaping national schemes.

    Impact Local care and construction employers can access funded AI training for their staff.

    What happened Barnsley will share over £800,000 from the government's AI Upskilling Challenge Fund across four local training projects, announced Tuesday 3 November. They cover hospital and care staff, firms in construction and engineering, women returning to work, and 20 small businesses.

  4. 21 OctNew

    Funding

    OpenAI buys Orchestra Bio to bring AI into drug development work

    Why it matters Biopharma teams now have OpenAI heading into their R&D operations, so reassess any AI workflow vendors you rely on.

    Impact Drug developers gain OpenAI-run AI for R&D operations, competing with existing workflow vendors.

    What happened OpenAI is buying Orchestra Bio, a company that applies AI to the day-to-day running of research and development in the life sciences. The aim is to help drug makers move treatments through development faster.

  5. 16 OctNew

    Programme

    OpenAI is giving university biology labs sponsored access to its science AI

    Why it matters Life sciences startups now compete for academic talent and partnerships with labs that get OpenAI's GPT-Rosalind through a sponsored plan.

    Impact Qualifying university biology labs get funded access to GPT-Rosalind and supporting tools.

    What happened OpenAI launched the Rosalind Academic Plan, which gives qualifying university research labs funded use of GPT-Rosalind plus supporting tools for life sciences work.

  6. 16 OctNew
    Google's AI platform helped scientists find a possible new antibiotic candidate, still untested in labs

    Why it matters Drug discovery teams can run a multi-database target search in one agent session, but the lead is only predicted, not lab-confirmed.

    Impact Agent platforms can scan protein databases for antibiotic leads, still awaiting lab validation.

    What happened Google DeepMind says biologists used its Antigravity agent platform to search millions of uncharacterized UniProt proteins with the ProtNLM model. They found one antimicrobial peptide candidate with predicted activity against respiratory pathogens, now in wet-lab validation.